Derivation of pancreatic acinar cell carcinoma cell line HS‐1 as a patient‐derived tumor organoid
暂无分享,去创建一个
M. Fukayama | T. Ushiku | Y. Hippo | Taketo Yamaguchi | O. Shimozato | A. Tsujimoto | M. Itami | Kazuyoshi Nakamura | K. Sudo | E. Kita | Yoshiaki Maru | R. Yokoyama | Yuki Nakamura | Hiroyuki Kogashi | Daisuke Hoshi | Yasutoshi Tatsumi | Atsushi Kato
[1] T. Noda,et al. Probing the tumorigenic potential of genetic interactions reconstituted in murine fallopian tube organoids , 2021, The Journal of pathology.
[2] N. Tanaka,et al. Kras activation in endometrial organoids drives cellular transformation and epithelial-mesenchymal transition , 2021, Oncogenesis.
[3] A. Nakajima,et al. Precision modeling of gall bladder cancer patients in mice based on orthotopic implantation of organoid-derived tumor buds , 2021, Oncogenesis.
[4] A. Hoffmeister,et al. Pitfalls in AR42J-model of cerulein-induced acute pancreatitis , 2021, PloS one.
[5] W. Lou,et al. Clinical Analysis of Acinar Cell Carcinoma of the Pancreas: A Single-Center Experience of 45 Consecutive Cases , 2020, Cancer control : journal of the Moffitt Cancer Center.
[6] H. Aburatani,et al. Organoid-based ex vivo reconstitution of Kras-driven pancreatic ductal carcinogenesis. , 2020, Carcinogenesis.
[7] Y. Ishii,et al. Establishment and Molecular Phenotyping of Organoids from the Squamocolumnar Junction Region of the Uterine Cervix , 2020, Cancers.
[8] C. Wilkinson,et al. Loss of Both CDKN2A and CDKN2B Allows for Centrosome Overduplication in Melanoma , 2020, The Journal of investigative dermatology.
[9] T. Imai,et al. An organoid-based carcinogenesis model induced by in vitro chemical treatment. , 2020, Carcinogenesis.
[10] N. Tanaka,et al. Establishment and characterization of patient‐derived organoids from a young patient with cervical clear cell carcinoma , 2019, Cancer science.
[11] N. Tanaka,et al. Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors. , 2019, Gynecologic oncology.
[12] T. Imai,et al. Kras-driven heterotopic tumor development from hepatobiliary organoids. , 2019, Carcinogenesis.
[13] T. Imai,et al. Shortcuts to intestinal carcinogenesis by genetic engineering in organoids , 2019, Cancer science.
[14] Hans Clevers,et al. A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening. , 2018, Cell stem cell.
[15] Hayley E. Francies,et al. Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics , 2018, Nature Communications.
[16] Satomi Takahashi,et al. Ex vivo model of non-small cell lung cancer using mouse lung epithelial cells. , 2017, Oncology letters.
[17] A. Ghaderi,et al. Establishment and characterization of a new human acinar cell carcinoma cell line, Faraz-ICR, from pancreas. , 2017, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[18] D. Coppola,et al. Systematic Review and Case Series Report of Acinar Cell Carcinoma of the Pancreas. , 2016, Cancer control : journal of the Moffitt Cancer Center.
[19] F. Couch,et al. Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin , 2016, Journal of Translational Medicine.
[20] H. Friess,et al. Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinoma , 2015, Molecular Cancer.
[21] Masakazu Yamamoto,et al. Whole exome sequencing reveals recurrent mutations in BRCA2 and FAT genes in acinar cell carcinomas of the pancreas , 2015, Scientific Reports.
[22] M. Spector,et al. Organoid Models of Human and Mouse Ductal Pancreatic Cancer , 2015, Cell.
[23] M. Gönen,et al. DNA Mismatch Repair Abnormalities in Acinar Cell Carcinoma of the Pancreas: Frequency and Clinical Significance , 2014, Pancreas.
[24] Weizhen Zhang,et al. Neurogenin 3–Directed Cre Deletion of Tsc1 Gene Causes Pancreatic Acinar Carcinoma , 2014, Neoplasia.
[25] M. Kloor,et al. Acinar cell carcinomas of the pancreas: a molecular analysis in a series of 57 cases , 2014, Virchows Archiv.
[26] P. Stephens,et al. Comprehensive genomic profiling of pancreatic acinar cell carcinomas identifies recurrent RAF fusions and frequent inactivation of DNA repair genes. , 2014, Cancer discovery.
[27] A. Nakagawara,et al. Receptor-type protein tyrosine phosphatase κ directly dephosphorylates CD133 and regulates downstream AKT activation , 2014, Oncogene.
[28] J. Herman,et al. Whole‐exome sequencing of pancreatic neoplasms with acinar differentiation , 2014, The Journal of pathology.
[29] T. Imai,et al. Genetic reconstitution of tumorigenesis in primary intestinal cells , 2013, Proceedings of the National Academy of Sciences.
[30] A. Vanoli,et al. Clinicopathologic Study of 62 Acinar Cell Carcinomas of the Pancreas: Insights Into the Morphology and Immunophenotype and Search for Prognostic Markers , 2012, The American journal of surgical pathology.
[31] Jing Pan,et al. Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing. , 2012, Carcinogenesis.
[32] M. Lowery,et al. Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy. , 2011, The oncologist.
[33] K. Anderson,et al. Mechanism of Action of Proteasome Inhibitors and Deacetylase Inhibitors and the Biological Basis of Synergy in Multiple Myeloma , 2011, Molecular Cancer Therapeutics.
[34] I. Rooman,et al. Lineage tracing evidence for transdifferentiation of acinar to duct cells and plasticity of human pancreas. , 2011, Gastroenterology.
[35] A. Molven,et al. Visualization of CD44 and CD133 in Normal Pancreas and Pancreatic Ductal Adenocarcinomas , 2011, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[36] J. Copland,et al. An Effective Personalized Approach to a Rare Tumor: Prolonged Survival in Metastatic Pancreatic Acinar Cell Carcinoma Based on Genetic Analysis and Cell Line Development , 2011, Journal of Cancer.
[37] H. Clevers,et al. Single Lgr5 stem cells build cryptvillus structures in vitro without a mesenchymal niche , 2009, Nature.
[38] D. Vigetti,et al. The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia , 2009, Virchows Archiv.
[39] K. Schulze-Osthoff,et al. Cancer stem cell markers in common cancers - therapeutic implications. , 2008, Trends in molecular medicine.
[40] A. Molven,et al. Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas , 2008, BMC Cancer.
[41] S. Lowe,et al. The p400 E1A-associated protein is a novel component of the p53 --> p21 senescence pathway. , 2005, Genes & development.
[42] M. Gonen,et al. Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas and related tumors. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] J. Cameron,et al. Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. , 2002, The American journal of pathology.
[44] M. Imamura,et al. K‐ras and p53 Alterations in Genomic DNA and Transcripts of Human Pancreatic Adenocarcinoma Cell Lines , 1994, Japanese journal of cancer research : Gann.
[45] N. Lemoine,et al. Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation. , 1993, The American journal of pathology.
[46] B. Wiedenmann,et al. The amphicrine pancreatic cell line, AR42J, secretes GABA and amylase by separate regulated pathways , 1992, FEBS letters.
[47] D. Klimstra,et al. Acinar Cell Carcinoma of the Pancreas: A Clinicopathologic Study of 28 Cases , 1992, The American journal of surgical pathology.
[48] J. Imanishi,et al. Characterization of new human pancreatic cancer cell lines which propagate in a protein-free chemically defined medium. , 1990, Cancer research.
[49] C. S. Wang. Purification of carboxyl ester lipase from human pancreas and the amino acid sequence of the N-terminal region. , 1988, Biochemical and biophysical research communications.
[50] R. Hammer,et al. Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice. , 1987, Science.
[51] S. Baithun,et al. Morphological study of 391 cases of exocrine pancreatic tumours with special reference to the classification of exocrine pancreatic carcinoma , 1985, The Journal of pathology.
[52] Y. Konishi,et al. Enhancement of pancreatic tumorigenesis of 4-hydroxyaminoquinoline 1-oxide by ethionine in rats. , 1976, Gan.
[53] A. Cubilla,et al. Morphological patterns of primary nonendocrine human pancreas carcinoma. , 1975, Cancer research.
[54] B. Barraclough,et al. Acute Pancreatitis: A Review. , 1972, The Australian and New Zealand journal of surgery.
[55] H. Kocher,et al. Pancreatic Cancer , 2019, Methods in Molecular Biology.
[56] Y. Hippo,et al. Lentivirus-Based Stable Gene Delivery into Intestinal Organoids. , 2016, Methods in molecular biology.
[57] E. Diamandis,et al. Pancreatic cancer. , 2013, Clinical chemistry.
[58] R. DePinho,et al. Genetics and biology of pancreatic ductal adenocarcinoma. , 2006, Genes & development.
[59] M. Nagai,et al. Frequency and Clinical Significance , 2005 .
[60] M. Rao,et al. Transplantable acinar cell carcinoma of the rat pancreas. , 1979, The American journal of pathology.